Altrinsic Global Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-254,700
Closed -$5.95M 81
2016
Q2
$5.95M Sell
254,700
-275,000
-52% -$5.95M 0.17% 53
2016
Q1
$9.96M Sell
529,700
-100,000
-16% -$1.76M 0.28% 52
2015
Q4
$11.6M Sell
629,700
-100,000
-14% -$1.79M 0.3% 51
2015
Q3
$12M Hold
729,700
0.28% 49
2015
Q2
$12.9M Sell
729,700
-100,000
-12% -$1.79M 0.26% 47
2015
Q1
$14.7M Sell
829,700
-200,000
-19% -$3.16M 0.32% 44
2014
Q4
$13.6M Hold
1,029,700
0.28% 45
2014
Q3
$12.2M Sell
1,029,700
-100,000
-9% -$1.26M 0.23% 49
2014
Q2
$14.4M Sell
1,129,700
-100,000
-8% -$1.3M 0.25% 48
2014
Q1
$16.6M Hold
1,229,700
0.29% 49
2013
Q4
$14.8M Hold
1,229,700
0.26% 45
2013
Q3
$14.4M Hold
1,229,700
0.25% 47
2013
Q2
$11.4M Buy
+1,229,700
New +$10.4M 0.2% 47

Other funds holding BSX

Altrinsic Global Advisors's BSX Position: Q3 2016 in Review

Altrinsic Global Advisors sold out of Boston Scientific (BSX) in Q3 2016, closing a stake of 254,700 shares — an estimated $5.95M sold.

Altrinsic Global Advisors first reported a position in BSX in Q2 2013 and held it in 13 quarters. The position peaked at $16.6M in Q1 2014. 568 funds tracked by Wall St. Rank hold BSX as of Q3 2016.

  • Altrinsic Global Advisors reported no remaining Boston Scientific position as of Q3 2016 after selling out during the quarter.
  • Altrinsic Global Advisors sold 254,700 Boston Scientific shares in Q3 2016, an estimated $5.95M.
  • Altrinsic Global Advisors first reported a position in Boston Scientific in Q2 2013 and held it in 13 quarters.
  • Altrinsic Global Advisors's Boston Scientific position peaked at $16.6M in Q1 2014.
  • 568 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2016.

Based on Altrinsic Global Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.